Literature DB >> 29467805

Reduction of Optic Disc Oedema by Bortezomib and Dexamethasone Followed by Autologous Peripheral Blood Stem Cell Transplantation in Patient with POEMS Syndrome.

Takehito Iwase1, Hirotaka Yokouchi1, Sonoko Misawa2, Toshiyuki Oshitari1, Takayuki Baba1, Satoshi Kuwabara2, Shuichi Yamamoto1.   

Abstract

The authors present findings in a 39-year-old man with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome with bilateral optic disc oedema. He was successfully treated with bortezomib and dexamethasone followed by autologous peripheral blood stem cell transplantation. The peripapillary retinal thickness was reduced in the optical coherence tomographic (OCT) images along with a decrease of the serum vascular endothelial growth factor (VEGF) levels. The authors recommend OCT to monitor the changes in the signs of POEMS syndrome after treatments.

Entities:  

Keywords:  Bortezomib; POEMS syndrome; optic disc oedema; optical coherence tomography; vascular endothelial growth factor

Year:  2017        PMID: 29467805      PMCID: PMC5812668          DOI: 10.1080/01658107.2017.1318406

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  21 in total

1.  Optical coherence tomography features of POEMS syndrome and Castleman disease-associated papillopathy.

Authors:  Monika Ecsedy; Miklos Schneider; Janos Nemes; Janos Nemeth; Zsuzsanna Recsan
Journal:  Ocul Immunol Inflamm       Date:  2014-02-24       Impact factor: 3.070

2.  OCT measurements in patients with optic disc edema.

Authors:  Marcel N Menke; Gilbert T Feke; Clement L Trempe
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-10       Impact factor: 4.799

3.  Is there a blood-brain barrier at the optic nerve head?

Authors:  M O Tso; C Y Shih; I W McLean
Journal:  Arch Ophthalmol       Date:  1975-09

4.  OCT for optic disc evaluation in idiopathic intracranial hypertension.

Authors:  Maren Skau; Dan Milea; Birgit Sander; Marianne Wegener; Rigmor Jensen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-10-15       Impact factor: 3.117

5.  POEMS syndrome in a 20-year-old patient diagnosed following a complaint of reduced visual acuity.

Authors:  Shinichiro Doi; Shuhei Kimura; Yuki Morizane; Mika Hosogi; Mio Hosokawa; Yusuke Shiode; Tetsuhiro Kawata; Eisei Kondo; Fumio Shiraga
Journal:  Acta Med Okayama       Date:  2014-12       Impact factor: 0.892

6.  Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial.

Authors:  Sonoko Misawa; Yasunori Sato; Kanako Katayama; Kengo Nagashima; Reiko Aoyagi; Yukari Sekiguchi; Gen Sobue; Haruki Koike; Ichiro Yabe; Hidenao Sasaki; Osamu Watanabe; Hiroshi Takashima; Masatoyo Nishizawa; Izumi Kawachi; Susumu Kusunoki; Yoshiyuki Mitsui; Seiji Kikuchi; Ichiro Nakashima; Shu-Ichi Ikeda; Nobuo Kohara; Takashi Kanda; Jun-Ichi Kira; Hideki Hanaoka; Satoshi Kuwabara
Journal:  Lancet Neurol       Date:  2016-08-03       Impact factor: 44.182

Review 7.  POEMS syndrome.

Authors:  Angela Dispenzieri
Journal:  Blood Rev       Date:  2007-09-11       Impact factor: 8.250

Review 8.  POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management.

Authors:  Angela Dispenzieri
Journal:  Am J Hematol       Date:  2014-02       Impact factor: 10.047

9.  Differential apicobasal VEGF signaling at vascular blood-neural barriers.

Authors:  Natalie Hudson; Michael B Powner; Mosharraf H Sarker; Thomas Burgoyne; Matthew Campbell; Zoe K Ockrim; Roberta Martinelli; Clare E Futter; Maria B Grant; Paul A Fraser; David T Shima; John Greenwood; Patric Turowski
Journal:  Dev Cell       Date:  2014-08-28       Impact factor: 12.270

Review 10.  Hematopoietic stem cell expansion and generation: the ways to make a breakthrough.

Authors:  Bokyung Park; Keon Hee Yoo; Changsung Kim
Journal:  Blood Res       Date:  2015-12-21
View more
  1 in total

1.  Reliability of optic disc edema area in estimating the severity of papilledema in patients with POEMS syndrome.

Authors:  Ling-Shan Liu; Xiao Zhang; Hao Zhao; Xue-Min Gao; Dao-Bin Zhou; Rong-Ping Dai; Jian Li
Journal:  Orphanet J Rare Dis       Date:  2020-05-19       Impact factor: 4.123

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.